Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

The estrogen receptor cofactor SPEN functions as a tumor suppressor and candidate biomarker of drug responsiveness in hormone-dependent breast cancers.

Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, Aleynikova O, Basik M.

Cancer Res. 2015 Aug 21. pii: canres.3475.2014. [Epub ahead of print]

PMID:
26297734
2.

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor.

Chang EH, Volpe BT, Mackay M, Aranow C, Watson P, Kowal C, Storbeck J, Mattis P, Berlin R, Chen H, Mader S, Huerta TS, Huerta PT, Diamond B.

EBioMedicine. 2015 May 30;2(7):755-64. doi: 10.1016/j.ebiom.2015.05.027. eCollection 2015 Jul.

3.

Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.

Giner XC, Cotnoir-White D, Mader S, Lévesque D.

FASEB J. 2015 Jul 6. pii: fj.14-259804. [Epub ahead of print]

PMID:
26148973
4.

Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.

Sankowski R, Mader S, Valdés-Ferrer SI.

Front Cell Neurosci. 2015 Feb 2;9:28. doi: 10.3389/fncel.2015.00028. eCollection 2015. Review.

5.

Dual gold-catalyzed head-to-tail coupling of iodoalkynes.

Mader S, Molinari L, Rudolph M, Rominger F, Hashmi AS.

Chemistry. 2015 Mar 2;21(10):3910-3. doi: 10.1002/chem.201406594. Epub 2015 Jan 23.

PMID:
25620322
6.

MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.

Medimegh I, Omrane I, Privat M, Uhrhummer N, Ayari H, Belaiba F, Benayed F, Benromdhan K, Mader S, Bignon IJ, Elgaaied AB.

PLoS One. 2014 Nov 4;9(11):e111877. doi: 10.1371/journal.pone.0111877. eCollection 2014.

7.

Udock, the interactive docking entertainment system.

Levieux G, Tiger G, Mader S, Zagury JF, Natkin S, Montes M.

Faraday Discuss. 2014;169:425-41. doi: 10.1039/c3fd00147d. Epub 2014 May 22.

PMID:
25341068
8.

Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence.

Medimegh I, Troudi W, Stambouli N, Khodjet-El-Khil H, Baroudi O, Ayari H, Omrane I, Uhrhammer N, Privat M, Mezlini A, Ayed FB, Romdhane KB, Mader S, Bignon YJ, Elgaaied AB.

Med Oncol. 2014 Nov;31(11):255. doi: 10.1007/s12032-014-0255-6. Epub 2014 Oct 2.

PMID:
25273865
9.

Peroxisomal biogenesis in ischemic brain.

Young JM, Nelson JW, Cheng J, Zhang W, Mader S, Davis CM, Morrison RS, Alkayed NJ.

Antioxid Redox Signal. 2015 Jan 10;22(2):109-20. doi: 10.1089/ars.2014.5833.

PMID:
25226217
10.

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.

Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, Karenfort M, Selch C, Häusler M, Eisenkölbl A, Salandin M, Gruber-Sedlmayr U, Blaschek A, Kraus V, Leiz S, Finsterwalder J, Gotwald T, Kuchukhidze G, Berger T, Reindl M, Rostásy K.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):265-72. doi: 10.1136/jnnp-2014-308346. Epub 2014 Aug 13.

PMID:
25121570
11.

Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise.

Souza JP, Widmer M, Gülmezoglu AM, Lawrie TA, Adejuyigbe EA, Carroli G, Crowther C, Currie SM, Dowswell T, Hofmeyr J, Lavender T, Lawn J, Mader S, Martinez FE, Mugerwa K, Qureshi Z, Silvestre MA, Soltani H, Torloni MR, Tsigas EZ, Vowles Z, Ouedraogo L, Serruya S, Al-Raiby J, Awin N, Obara H, Mathai M, Bahl R, Martines J, Ganatra B, Phillips SJ, Johnson BR, Vogel JP, Oladapo OT, Temmerman M.

Reprod Health. 2014 Aug 7;11:61. doi: 10.1186/1742-4755-11-61.

12.

Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1.

Calderon MR, Verway M, Benslama RO, Birlea M, Bouttier M, Dimitrov V, Mader S, White JH.

Nucleic Acids Res. 2014 Jun;42(11):7012-27. doi: 10.1093/nar/gku413. Epub 2014 May 14.

13.

LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.

Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M.

Int J Cancer. 2014 Sep 15;135(6):1307-18. doi: 10.1002/ijc.28781. Epub 2014 Mar 4.

PMID:
24615515
14.

Public-private collaboration in clinical research during pregnancy, lactation, and childhood: joint position statement of the Early Nutrition Academy and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Koletzko B, Benninga MA, Godfrey KM, Hornnes PJ, Kolaček S, Koletzko S, Lentze MJ, Mader S, McAuliffe FM, Oepkes D, Oddy WH, Phillips A, Rzehak P, Socha P, Szajewska H, Symonds ME, Taminiau J, Thapar N, Troncone R, Vandenplas Y, Veereman G.

J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):525-30. doi: 10.1097/MPG.0000000000000284.

PMID:
24399212
15.

T cell-activation in neuromyelitis optica lesions plays a role in their formation.

Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer MT, Machado-Santos J, Mader S, Ellwart JW, Misu T, Fujihara K, Wekerle H, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol Commun. 2013 Dec 24;1:85. doi: 10.1186/2051-5960-1-85.

16.

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.

Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M.

Acta Neuropathol Commun. 2013 May 8;1:5. doi: 10.1186/2051-5960-1-5.

17.

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.

PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013.

18.

NIDCAP Federation International response.

Lawhon G, Helm JM, Buehler D, McAnulty G, Kosta S, Alberts JR, Als H, Mader S, Daly M, Sizun J, Vandenberg K, Warren I.

Pediatrics. 2013 Aug;132(2):e550-1. doi: 10.1542/peds.2013-1447B. No abstract available.

19.

Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.

Gredler V, Mader S, Schanda K, Hegen H, Di Pauli F, Kuenz B, Deisenhammer F, Berger T, Reindl M, Lutterotti A.

J Neurol Sci. 2013 May 15;328(1-2):77-82. doi: 10.1016/j.jns.2013.02.024. Epub 2013 Mar 21.

PMID:
23522498
20.

Brain-reactive antibodies and disease.

Diamond B, Honig G, Mader S, Brimberg L, Volpe BT.

Annu Rev Immunol. 2013;31:345-85. doi: 10.1146/annurev-immunol-020711-075041. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk